CHROMOSOMAL DISORDERS: TRISOMIES AND DELETIONS
“๐ฃ๐ธ ๐พ๐ท๐ญ๐ฎ๐ป๐ผ๐ฝ๐ช๐ท๐ญ ๐ฝ๐ฑ๐ฎ ๐ธ๐ป๐ฐ๐ช๐ท๐ฒ๐ผ๐ถ, ๐ธ๐ท๐ฎ ๐ถ๐พ๐ผ๐ฝ ๐พ๐ท๐ญ๐ฎ๐ป๐ผ๐ฝ๐ช๐ท๐ญ ๐ฒ๐ฝ๐ผ ๐ฌ๐ฑ๐ป๐ธ๐ถ๐ธ๐ผ๐ธ๐ถ๐ฎ๐ผ ๐ฒ๐ท ๐ฝ๐ฑ๐ฎ๐ฒ๐ป ๐ท๐ธ๐ป๐ถ๐ช๐ต ๐ผ๐ฝ๐ช๐ฝ๐ฎ ๐ช๐ท๐ญ ๐๐ฑ๐ฎ๐ท ๐ป๐ฎ๐ช๐ป๐ป๐ช๐ท๐ฐ๐ฎ๐ญ.” - Barbara McClintock
๐งฌ Chromosomal disorders arise from abnormalities in chromosome number or structure, disrupting gene dosage and developmental pathways. Among them, trisomies & deletions are clinically and biologically significant due to their impact on embryogenesis, neurodevelopment, and long-term health.
๐น Down syndrome (Trisomy 21) is the most prevalent autosomal trisomy compatible with postnatal survival. It is characterized by intellectual disability, congenital heart defects, endocrine dysfunction, and increased leukemia & early-onset Alzheimer risk. Other severe trisomies include:
• Edwards syndrome
• Patau syndrome
These conditions often result in profound multisystem anomalies & high neonatal mortality. Most trisomies arise from meiotic nondisjunction, particularly maternal meiosis I errors, with risk increasing with advanced maternal age. The additional chromosome leads to global transcriptional imbalance; altering regulatory networks beyond the triplicated genes themselves.
๐น Chromosomal deletions remove genomic segments, leading to haploinsufficiency where a single functional copy of a gene is insufficient for normal function.
Key examples include:
•Cri du chat syndrome characterized by a high-pitched neonatal cry, developmental delay, and microcephaly.
•DiGeorge syndrome associated with conotruncal heart defects, thymic hypoplasia, hypocalcemia, and neuropsychiatric risk. Phenotypic variability reflects deletion size, gene content, and modifying genomic/environmental factors.
๐น Diagnostic tools have evolved from classical cytogenetics to high-resolution genomics:
• #Karyotyping detects aneuploidies & large structural changes.
• #CMA identifies submicroscopic deletions/duplications.
• #NGS enables fine-scale structural variant detection.
• #NIPT analyzes cell-free fetal DNA for common trisomies with high sensitivity.
These technologies have transformed prenatal screening, postnatal diagnosis, and genotype-phenotype correlation research.
➡️ Management is multidisciplinary; integrating cardiology, neurology, endocrinology, developmental therapy, and psychosocial support. Early intervention significantly improves cognitive & adaptive outcomes, particularly in Down syndrome. Balanced, non-directive genetic counseling remains essential.
⚠️ In an Oystershell, trisomies & deletions exemplify how genomic imbalance reshapes human development. Advancing molecular diagnostics & systems biology continues to refine our understanding of gene dosage sensitivity & chromosomal architecture.
Abubakar Abubakar ✍๐ป
• Wapner RJ, et al. (2012). N.E.J of Medicine, 367:2175-2184.
• Riggs ER, et al. (2020). Genetics in Medicine, 22:245-257.
Comments
Post a Comment